extract from an article on Seeking Alpha
For the pediatric trial, however, there is really nothing left to discuss. The trial was a failure. How much of an effect the pediatric Rett data will have on the rest of the pipeline is anyone's guess, but for now, the stock has taken a terrible beating, going down losing 40% overnight.The company did try to explain the poor show by claiming a very strong placebo effect, but their reasons sounded hollow.
- Forums
- ASX - By Stock
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
extract from an article on Seeking Alpha For the pediatric...
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.91 |
Change
-0.030(0.15%) |
Mkt cap ! $2.544B |
Open | High | Low | Value | Volume |
$19.95 | $20.00 | $19.50 | $8.294M | 417.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 443 | $19.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.91 | 917 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3395 | 19.750 |
3 | 6690 | 19.720 |
1 | 1119 | 19.710 |
1 | 1192 | 19.700 |
1 | 1119 | 19.670 |
Price($) | Vol. | No. |
---|---|---|
19.940 | 1119 | 1 |
19.960 | 528 | 1 |
19.980 | 1119 | 1 |
20.000 | 52 | 1 |
20.030 | 1119 | 1 |
Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online